Lupin’s Japanese subsidiary announces drug price for Bipresso tablets

According to pharmaceutical major Lupin, its Japanese subsidiary, Kyowa Pharmaceuticals Industry Company, has announced the listing of the National Health Insurance (NHI) drug price for Bipresso Extended-Release 50 mg and 150 mg tablets. The company has decided the price at 71 Japanese yen (Rs 41.37 approximately) for 50 mg tables and 188 Japanese yen (Rs 109.55 approximately) for 150 mg tables.
 
The drug is used for the treatment of depressive symptoms associated with bipolar disorder. The tablet contains the active ingredient Quetiapine Fumarate and is an extended-release tablet to be taken orally once a day. 
 
Kyowa is a Japanese subsidiary of the Lupin Ltd. It develops, manufactures and sells branded and generic pharmaceutical products for patients in the Japanese market.
 
Meanwhile, the stock was trading up by 0.74% at Rs 995 per share on the BSE at 1007 hours. The stock opened at Rs 990 per share and touched its intraday high and low at Rs 999 and Rs 990 per share, respectively. The stock attracted a total traded volume of 1,46,717 shares and traded value of Rs 1,460.26 lakhs on the NSE at 1005 hours. The stock’s 52-week high was at Rs 1,588.40 as on September 8, 2016 and its 52-week low was at Rs 917.55 as on August 10, 2017.